#BioSpace highlights how #GamidaCell with its lead #stemcelltherapy candidate #omidubicel, if approved, may level the racial playing field for bone marrow transplants. https://t.co/LKLYeE22aa #BeTheMatch #HealthEquity #HealthDiversity #ASCO2022 #BloodCancers #ASTCT #CIBMTR https://t.co/hmfe3IqYgv
Each year, many eligible patients do not receive an allogeneic stem cell transplant. How can we harness emerging vistas in cellular engineering to redefine who can make the transplant journey? Visit https://t.co/TAeQiTApuA to join us in our effort to expand the transplant horizon https://t.co/E9S19Wpovf
Stem cell research was the focus of #ISSCR2022. Our lead Allo stem cell therapy candidate #omidubicel has the potential to improve health outcomes and #healthdisparities for minority cancer patients based on HEOR study. https://t.co/g0PFHn6aOK #StemCellTransplant #HealthEquity https://t.co/eIvLypAmzg
The needs and experiences of patients are at the core of our mission and purpose. Read about one woman’s personal journey through cancer diagnosis, treatment and more than 10 years as a survivor.
We are creating a pipeline of advanced cell therapies designed to deliver a curative approach for patients with cancer.
We combine bold and creative pursuits in science with a passion for curing cancer so that patients can live longer, better lives.